In light of the important role of psychosocial factors in the development of insulin resistance, type 2 diabetes, and other chronic diseases, the influence of sympathetic activation in the pathogenesis of insulin resistant states and the bidirectional relationships of these and other insulin resistance-related risk factors and mind-body therapies may hold promise for both the prevention and treatment of the metabolic syndrome. This evidence concerns the gene INS and Insulin resistance.